9 hours ago Patient Portal. Patients can message their clinic, check test results, and view upcoming appointments and past clinical summaries through our secure site. Employee Portal. ADP Portal Access for current MPA employees is a self-service portal. KU School of Medicine-Wichita. 1010 North Kansas Wichita, KS 67214-3199 >> Go To The Portal
The MyUofMHealth Patient Portal is a secure way to manage your health, offering a 24/7 connection to Michigan Medicine and your important health information. Through the portal you can:
HIPAA-compliant, secure way to communicate with your Doctors and Healthcare Providers View, download, and share parts of your UNM health record
Please try again later. is a secure way to manage your health, offering a 24/7 connection to Michigan Medicine and your important health information. Through the portal you can: if you don’t already have one.
Some of our policies and procedures have changed due to the pandemic. Those of particular interest to our patients are listed below.
The MyUofMHealth Patient Portal (link is external) is a secure way to manage your health, offering a 24/7 connection to Michigan Medicine and your important health information. Through the portal you can:
For questions or more information about the MyUofMHealth Patient Portal (link is external) contact our Health Information Management Department:
KU Wichita Internal Medicine Midtown provides primary care services by University of Kansas School of Medicine-Wichita faculty.
The entire staff functions as a team to make your visit as pleasant and efficient as possible. We take pride in the training, knowledge, skills, and professionalism of our team, and we trust that you will share this feeling of confidence.
Our faculty and resident physicians are at a number of facilities throughout the week. Our nurses will routinely contact doctors during the day and relay your messages. Unless it is an emergency, expect a response later in the day.
The University of Kansas School of Medicine-Wichita Center for Clinical Research has resumed leading the local effort of a nationwide clinical trial brought through the COVID-19 Prevention Network testing the COVID-19 vaccine AZD1222, developed by Oxford University and purchased by AstraZeneca.